APPOINT Program released in Health Services Hub

As a pharmacist, you have unique expertise, experience and patient access. Patients can present to you anytime and ask for health advice. Like GPs and specialists, the role of pharmacy is equally vital in addressing untreated, unmanaged fracture risk to prevent the serious consequences of osteoporosis.

Recognising the critical role that pharmacy plays in identifying and treating osteoporosis Amgen Australia has joined with PharmaPrograms to create the Amgen Pharmacy Partnership in Osteoporosis INTervention (APPOINT) Program with the aim of supporting pharmacies like yours to reduce osteoporotic frac tures.

This Program will enable pharmacists to play a greater role in osteoporosis treatment. To register for the Program, please click here, or call PharmaPrograms on 1300 377 781 to obtain your PharmaPrograms ID.

The APPOINT Program will launch in stages, beginning with the Module 1: Risk Assessment Screening to patients, which you can provide to patients from today and record within Health Services Hub.

The Module 1: Risk Assessment screening is designed to identify patients who may be at risk of osteoporosis, and should be referred back to their doctor to discuss their bone health. The professional service fee for providing this service is $12 per completed screening.